| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
315 |
| issn |
1948-5875 |
| issueIdentifier |
3 |
| pageRange |
314-315 |
| publicationName |
ACS Medicinal Chemistry Letters |
| startingPage |
314 |
| bibliographicCitation |
Sabnis RW. Novel Benzimidazole Derivatives as Transient Receptor Potential Channel 6 (TRPC6) Inhibitors. ACS Med. Chem. Lett. 2021 Feb 12;12(3):314–5. doi: 10.1021/acsmedchemlett.1c00056. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7289-0581 |
| date |
2021-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/33738049
https://doi.org/10.1021/acsmedchemlett.1c00056
https://pubmed.ncbi.nlm.nih.gov/PMC7957910 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1948-5875
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Novel Benzimidazole Derivatives as Transient Receptor Potential Channel 6 (TRPC6) Inhibitors |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78dc14c2fb79bd47f6db00202926e5da |